Trial Profile
Named Patient Program With Certolizumab Pegol in Adults Suffering From Rheumatoid Arthritis (RA) Who Participated in Open Label Studies C87015, C87028 and C87051
Status:
Recruiting
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 02 Aug 2023
Price :
$35
*
At a glance
- Drugs Certolizumab pegol (Primary)
- Indications Rheumatoid arthritis
- Focus Expanded access; Therapeutic Use
- Sponsors UCB Biopharma
- 26 Jun 2018 New trial record